How should propranolol be dosed for anxiety in an adult without significant cardiac, respiratory, or metabolic contraindications?

Propranolol Dosing for Anxiety in Adults

Dosing Strategy by Anxiety Type

For situational or performance anxiety (e.g., public speaking, specific social situations), take 10–20 mg of immediate-release propranolol 30–60 minutes before the anxiety-provoking event, with a maximum single dose of 40 mg. 1, 2

For chronic or generalized anxiety requiring daily treatment, start immediate-release propranolol 40 mg twice daily (80 mg total daily) and titrate to 80–160 mg daily in 2 divided doses based on symptom response. 1

Situational (As-Needed) Dosing

• Best for: Patients with infrequent, predictable anxiety triggers and prominent physical symptoms (tremor, palpitations, sweating, tachycardia) 1, 2
• Timing: Administer 30–60 minutes before the anticipated event 1
• Dose range: 10–20 mg per event; do not exceed 40 mg as a single dose 1
• Evidence: The Japanese Society of Anxiety and Related Disorders confirms propranolol is effective for performance anxiety but deprecates it for generalized social anxiety disorder 1

Chronic Daily Dosing

• Best for: Patients with frequent anxiety episodes or ongoing symptoms requiring continuous control 1
• Immediate-release formulation:
  • Start 40 mg twice daily (80 mg total) 1
  • Titrate every 4–7 days to 80–160 mg daily in 2 divided doses 1, 3
  • Typical effective range: 80–160 mg daily 1
  • Maximum: 640 mg daily if needed (rarely required) 1
• Long-acting formulation:
  • Start 80 mg once daily 1
  • Titrate to 120–160 mg once daily 1
  • Better compliance due to once-daily dosing 3

Hybrid Approach (For Patients with Both Conditions)

• Maintain a baseline daily dose (e.g., 80 mg/day in divided doses) and add a supplemental 10–20 mg immediate-release dose 30–60 minutes before known anxiety-provoking events 1
• Maximum single situational dose should not exceed 40 mg 1

---

Patient Selection: Who Benefits Most

Propranolol is most effective for patients whose anxiety manifests primarily as somatic/autonomic symptoms—tremor, palpitations, tachycardia, sweating—rather than predominantly psychological symptoms like worry or rumination. 1, 2, 4

• Patients with "somatic anxiety" respond significantly better than those with "psychic anxiety" 4
• Propranolol reduces observable physical signs of anxiety (tremor, sweating) and self-reported anxiety in anxious individuals 5
• Historical data show 80–320 mg daily sufficed for most patients, with relief of both somatic and psychic symptoms in the majority 6

---

Mandatory Pre-Treatment Assessment

Before prescribing propranolol, screen for absolute contraindications and perform a baseline cardiovascular assessment. 1, 3, 2

Absolute Contraindications (Do Not Prescribe)

• Second- or third-degree atrioventricular block (without pacemaker) 1, 3, 2
• Decompensated heart failure or significant left ventricular dysfunction 1, 2
• Asthma or obstructive airway disease (can precipitate life-threatening bronchospasm) 1, 2
• Cardiogenic shock 1, 3
• Sinus node dysfunction or sinus bradycardia (without pacemaker) 1, 3
• Severe hypotension 1

Baseline Assessment

• Measure heart rate and blood pressure 1, 3
• Perform cardiovascular examination with auscultation 1
• Screen for history of bronchospasm, diabetes, and concurrent medications affecting cardiac conduction 1, 3
• No routine ECG, echocardiogram, or blood work required in otherwise healthy adults without cardiac concerns 1

Special Populations

• Diabetic patients: Use with extreme caution; propranolol masks adrenergic warning signs of hypoglycemia (tremor, tachycardia, sweating), requiring more frequent glucose monitoring and reliance on non-adrenergic cues (hunger, confusion) 1, 2
• Elderly patients: May require lower doses due to altered pharmacokinetics 1

---

Critical Safety Warnings

Drug Interactions

Avoid routine combination with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to markedly increased risk of severe bradycardia and heart block. 1, 3, 2

• Propranolol is contraindicated with dofetilide 1
• CYP3A4 inhibitors (diltiazem, verapamil) can elevate propranolol concentrations 1

Discontinuation

Never abruptly discontinue propranolol after chronic use; taper gradually over 1–3 weeks to prevent rebound hypertension, tachycardia, or angina. 1, 3

Administration Recommendations

• Take with food to reduce risk of hypoglycemia 1
• Hold doses during times of diminished oral intake, vomiting, or acute illness 1

---

Monitoring During Treatment

For As-Needed Use

• No routine monitoring required for occasional situational use in healthy patients 2
• Instruct patients to check pulse before taking propranolol and hold the dose if heart rate is below 60 bpm 2

For Chronic Daily Use

• Monitor heart rate and blood pressure, especially during dose escalation 1, 3
• Watch for adverse effects: hypotension, bradycardia, fatigue, dizziness, cold extremities, bronchospasm 1, 3
• No routine vital sign monitoring required between appointments if patient is stable and asymptomatic 1

Signs of Excessive Beta-Blockade (Instruct Patients to Report)

• Dizziness or light-headedness 1
• Marked fatigue 1
• Heart rate below 50 bpm 1
• Systolic blood pressure below 90 mmHg 1
• New or worsening shortness of breath or wheezing 1

---

Pharmacokinetic Considerations

Immediate-Release Formulation

• Half-life: 3–6 hours 1
• Requires dosing 2–4 times daily for most indications 1, 3
• Twice-daily dosing acceptable for hypertension and anxiety 1

Long-Acting (Extended-Release) Formulation

• Half-life: 8–20 hours 1
• Allows once-daily dosing 1, 3
• Improves compliance 3

---

Common Pitfalls and How to Avoid Them

1. Using propranolol for predominantly psychological anxiety: Propranolol works best for somatic symptoms; patients with primarily cognitive/worry symptoms may not respond 4

2. Prescribing to asthmatics: This is an absolute contraindication due to risk of life-threatening bronchospasm 2

3. Combining with diltiazem or verapamil: This combination markedly increases bradycardia and heart block risk 1, 3, 2

4. Abrupt discontinuation: Always taper over 1–3 weeks to prevent rebound hypertension and tachycardia 1, 3

5. Ignoring hypoglycemia risk in diabetics: Propranolol masks typical warning signs; counsel patients to monitor glucose more frequently 1, 2

6. Overdosing for situational anxiety: A single 40 mg dose is the maximum for as-needed use; higher doses do not improve efficacy and increase side effects 1

---

Evidence Quality and Nuances

The dosing recommendations are derived from strong guideline evidence from the American College of Cardiology and American Heart Association 1, 3, with supporting data from older but well-designed placebo-controlled trials 7, 6, 8, 5, 4. The distinction between somatic and psychic anxiety is critical: propranolol was significantly more effective than placebo in patients with somatic anxiety but not in those with psychic anxiety 4. Historical long-term studies show that 80–320 mg daily sufficed for most patients, with some requiring up to 1200 mg temporarily for intense symptoms 6, though contemporary guidelines recommend a maximum of 640 mg daily 1.